ES2103825T3 - Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales. - Google Patents

Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.

Info

Publication number
ES2103825T3
ES2103825T3 ES91915307T ES91915307T ES2103825T3 ES 2103825 T3 ES2103825 T3 ES 2103825T3 ES 91915307 T ES91915307 T ES 91915307T ES 91915307 T ES91915307 T ES 91915307T ES 2103825 T3 ES2103825 T3 ES 2103825T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
metilsulfinil
difluorometoxi
bencimidazole
dimetoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915307T
Other languages
English (en)
Inventor
Michael E Parsons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10681166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2103825(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Application granted granted Critical
Publication of ES2103825T3 publication Critical patent/ES2103825T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE PRESENTAN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UN AGENTE ANTIMICROBIANO INHIBIDOR DE LAS HELICOBACTERIAS Y UN DERIVADO DE LA BENCIMIDAZOLA QUE TIENEN ACTIVIDAD INHIBITORIA DE LA SECRECCION DEL ACIDO GASTRICO.
ES91915307T 1990-08-24 1991-08-23 Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales. Expired - Lifetime ES2103825T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909018603A GB9018603D0 (en) 1990-08-24 1990-08-24 Compositions

Publications (1)

Publication Number Publication Date
ES2103825T3 true ES2103825T3 (es) 1997-10-01

Family

ID=10681166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915307T Expired - Lifetime ES2103825T3 (es) 1990-08-24 1991-08-23 Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.

Country Status (13)

Country Link
EP (1) EP0544760B1 (es)
JP (1) JPH06503806A (es)
KR (1) KR930701166A (es)
AT (1) ATE152350T1 (es)
AU (1) AU658831B2 (es)
CA (1) CA2089748C (es)
CY (1) CY2167B1 (es)
DE (1) DE69125940T2 (es)
DK (1) DK0544760T3 (es)
ES (1) ES2103825T3 (es)
GB (1) GB9018603D0 (es)
GR (1) GR3024058T3 (es)
WO (1) WO1992003135A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW276996B (es) * 1992-04-24 1996-06-01 Astra Ab
WO1994013290A1 (de) * 1992-12-10 1994-06-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien
WO1994027606A1 (en) * 1993-05-28 1994-12-08 Unisearch Limited Method of treating helicobacter pylori infection
EP0995447A1 (en) * 1993-09-09 2000-04-26 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
TW420610B (en) * 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
JP3042890B2 (ja) * 1994-11-21 2000-05-22 ファイザー製薬株式会社 フタリド化合物及びその製法
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6303644B1 (en) * 1997-07-25 2001-10-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Proton pump inhibitor in therapeutic combination with antibacterial substances
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
CA2089748A1 (en) 1992-02-25
CA2089748C (en) 2005-07-05
EP0544760B1 (en) 1997-05-02
ATE152350T1 (de) 1997-05-15
GB9018603D0 (en) 1990-10-10
WO1992003135A1 (en) 1992-03-05
EP0544760A1 (en) 1993-06-09
DK0544760T3 (da) 1997-09-22
CY2167B1 (en) 2002-08-23
AU8424091A (en) 1992-03-17
KR930701166A (ko) 1993-06-11
AU658831B2 (en) 1995-05-04
JPH06503806A (ja) 1994-04-28
GR3024058T3 (en) 1997-10-31
DE69125940T2 (de) 1997-12-18
DE69125940D1 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
DK1382348T3 (da) Polynukleotidvaccineformulering, især til behandling af bovin luftvejssygdom
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
BR9201253A (pt) Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
DK88087A (da) Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ATE87476T1 (de) Fluessige orale formulierung.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
ES2166912T3 (es) Composiciones, que comprenden bismuto y uno o mas agentes antimicrobianos, para el tratamiento y prevencion de trastornos gastrointestinales.
SE8105500L (sv) Psykotropa lekemedel
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 544760

Country of ref document: ES